Dan Xie
谢丹
Dan Xie is a Chinese biotech entrepreneur and bioinformatics specialist, best known as co-founder of Qitan Technology (齐碳科技), a domestic nanopore gene sequencing company that has raised multiple funding rounds including a RMB 700 million Series C in late 2022 . He holds a PhD from the University of Illinois at Urbana-Champaign and completed postdoctoral work at Stanford University . In Qitan's early years, Xie described the company as having "buried its head in technology" to cross through an "academic no-man's-land" before pushing toward mass production . The company has positioned nanopore sequencing for applications in infectious disease diagnosis, genetic disease and tumor mutation detection, and forensic science .
*Note: The retrieved corpus does not cover any other "Dan Xie" — the entity card and relations point unambiguously to the Qitan Technology co-founder, not the individuals mentioned in the 5Y Capital background piece about AI founders.*
AI-generated — may contain errors, please verify.
Coverage
Qitan Tech Closes RMB 700 Million Series C Round to Advance Commercialization of Domestic Nanopore Sequencing Technology
Breaking Through the "Mass-Production No-Man's-Land" of Domestic Nanopore Sequencing
Qitan Tech Raises Over 400 Million Yuan in Series B, Leading the Nanopore Gene Sequencer Race
China's first fully self-developed nanopore gene sequencer is slated for mass production later this year.
Leading nanopore gene sequencing company **Qitan Technology** has raised over RMB 100 million in funding, led by Gaorong Ventures.
Focused on the independent R&D of nanopore gene sequencers, dedicated to making gene sequencing technology accessible to every household.
